Rash as a Prognostic Factor in West Nile Virus Disease
Author(s) -
Gregory Huhn,
Mark S. Dworkin
Publication year - 2006
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/505606
Subject(s) - medicine , rash , west nile virus , virology , disease , virus , dermatology
Muto CA. Sustained effect in reducing methicillin-resistant Staphylococcus aureus (MRSA) hospital acquired infections (HAIs) using active MRSA surveillance cultures (MSC)— three-year follow-up [abstract 22]. In: Conference of the 15th Annual Society for Healthcare Epidemiology of America (Los Angeles, CA). 2005:64. 10. Huang SS, Yokoe DS, Rego VH, et al. Impact of ICU surveillance for MRSA on bacteremia [abstract 1074]. In: 43rd Annual Meeting of The Infectious Diseases Society of America (San Francisco, CA). 2005:237. 11. Sommer A. SARS: paradigm for an emerging pathogen in a global community. In: the opening plenary session of the Fourteenth Annual Meeting of The Society for Healthcare Epidemiology of America (Philadelphia, PA). 2004. 12. Beck-Sague CM, Dooley SW, Hutton MD, et al. Outbreak of multidrug-resistant tuberculosis among persons with HIV infection in an urban hospital: transmission to staff and patients and control measures. JAMA 1992; 268: 1280–6. 13. Byers KE, Anglim AM, Anneski CJ, et al. A hospital epidemic of vancomycin-resistantEnterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001; 22:140–7. 14. Christiansen KJ, Tibbett PA, Beresford W, et al. Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital. Infect Control Hosp Epidemiol 2004; 25:384–90. 15) Mascini EM, Troelstra A, Beitsma M, et al. Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium. Clin Infect Dis 2006; 42: 739–46. 16. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001; 344:1427–33. 17. Sunenshine RH, Liedtke LA, Fridkin SK, Strausbaugh LJ, Infectious Diseases Society of America Emerging Infections Network. Management of inpatients colonized or infected with antimicrobial-resistant bacteria in hospitals in the United States. Infect Control Hosp Epidemiol 2005; 26:138–43. 18. Marshall C, Harrington G, Wolfe R, Fairley CK, Wesselingh S, Spelman D. Acquisition of methicillin-resistant Staphylococcus aureus in a large intensive care unit. Infect Control Hosp Epidemiol 2003; 24:322–6. 19. Karchmer TB, Jernigan LJ, Durbin LJ, Simonton BM, Farr BM. Eradication of MRSA colonization with different regimens [abstract 65]. In: the Ninth Annual Meeting of the Society for Healthcare Epidemiology of America, (San Francisco, CA). 1999:42. 20. Boyce JM, Cookson B, Christiansen K, et al. Methicillin-resistant Staphylococcus aureus. Lancet Infect Dis 2005; 5:653–63. 21. Muto CA, Jernigan JA, Ostrowksy BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24:362–86.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom